Need Regulatory Help? Try Our Platform
Post your regulatory questions or request quotations from verified pharmaceutical consultants worldwide. Get matched with experts who specialize in your market.
January 15, 2026
Approximately 5 minutes
Determining the Kind of Medical Device for TGA Inclusion – Australian Regulatory Overview
Determining the Kind of Medical Device for TGA Inclusion – Australian Regulatory Overview
Overview of Device Classification and Inclusion
In Australia, all medical devices must be included in the Australian Register of Therapeutic Goods (ARTG) before supply, except for exempt devices. The Therapeutic Goods Administration (TGA) classifies devices into four risk-based classes (I, IIa, IIb, III) according to the level of potential harm and intended use. Correct classification determines conformity assessment procedures, evidence requirements, and whether a device can be considered a variant of an already included device or requires a separate ARTG entry. Source: What kind of medical device is it? - TGA
Key Factors in Determining Device Kind
Intended Purpose
The intended purpose, as stated by the manufacturer, is the primary determinant of classification and whether a device falls within the same kind as an existing ARTG entry. Changes in intended purpose (e.g., new clinical claims) typically require a separate entry.
Design and Technological Differences
Devices are considered the same kind if they have the same intended purpose and do not differ significantly in design, materials, or technology. Minor variations (e.g., size range, colour) may qualify as variants within the same ARTG entry, while substantial changes (e.g., new active ingredient, major material change) usually require separate inclusion.
Risk-Based Classification Rules
Classification follows Schedule 2 of the Therapeutic Goods (Medical Devices) Regulations 2002:
- Class I: Low risk (e.g., non-invasive, reusable surgical instruments)
- Class IIa: Low-medium risk (e.g., invasive short-term, active therapeutic low-risk)
- Class IIb: Medium-high risk (e.g., invasive long-term, active therapeutic medium-risk)
- Class III: High risk (e.g., implantable, active life-supporting)
Variant Rules
A variant is a medical device that:
- Has the same sponsor and manufacturer
- Shares the same intended purpose
- Differs only in aspects permitted under TGA variant guidelines (e.g., dimensions within a range, packaging differences)
- Does not introduce new risks or change the risk classification
Variants can be included under the same ARTG entry, reducing administrative burden.
Process Implications
- Same Kind/Variant: Can be added to existing ARTG entry via amendment (faster, lower cost)
- Different Kind: Requires new ARTG inclusion application with full conformity assessment evidence
- Incorrect classification or variant determination can lead to compliance actions, including cancellation of ARTG entry
Practical Guidance for Manufacturers
- Review the intended purpose wording carefully
- Compare design specifications against existing ARTG entries
- Use TGA classification tools and guidance documents
- Consult TGA if uncertainty exists regarding variant status
This framework ensures risk-proportionate regulation while allowing efficient inclusion of minor product variations. Detailed classification rules, variant examples, and decision trees are provided in the official TGA guidance on determining the kind of medical device. Source: What kind of medical device is it? - TGA
The content reflects TGA requirements as of the latest available guidance and supports manufacturers in achieving compliant market entry in Australia.
Ask Anything
We'll follow up with you personally.
Related Articles
Approximately 5 minutes
Overview of Medical Devices and IVD Regulation in Australia – TGA Framework
The Therapeutic Goods Administration (TGA) regulates medical devices and in vitro diagnostic (IVD) medical devices in Australia through a risk-based approach, classifying devices from Class I (lowest risk) to Class III (highest risk for devices) and IVDs from Class 1 to Class 4, requiring inclusion in the Australian Register of Therapeutic Goods (ARTG), conformity assessment, and ongoing post-market surveillance to ensure safety, performance, and quality.
Approximately 5 minutes
Regulation Essentials for Therapeutic Goods in Australia – TGA Core Requirements
The Therapeutic Goods Administration (TGA) regulates therapeutic goods—including medicines, medical devices, biologicals, and blood components—through a risk-based framework under the Therapeutic Goods Act 1989, requiring registration/listing/inclusion in the ARTG, conformity to quality/safety/efficacy standards, manufacturing compliance (GMP), labelling/advertising rules, and post-market monitoring to protect public health in Australia.